Tirzepatide, a innovative medication, is creating considerable interest in the scientific community. Originally designed as a treatment for diabetes type 2, it has unexpectedly shown significant effects regarding body composition. Clinical trials suggest that tirzepatide, acting through a novel mechanism targeting the incretin hormones, may lead to

Tirzepatide, the recently approved medication, is generating considerable interest within the scientific community. It operates differently from common diabetes medications, targeting multiple receptors involved in glucose regulation and hunger . Initial studies have demonstrated remarkable efficacy in reducing blood glucose in individuals with dia